$112.53
-0.13%AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.
Acceptable margins but limited operational leverage. Operating expense control is important.
Strong net margins indicate efficient operations and favorable tax/interest management.
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
ATR โข NYSE
| AptarGroup, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
3.8B | 3.6B | 3.5B | 3.3B | 3.2B | 2.9B | 2.9B | 2.8B | 2.5B | 2.3B | 2.3B | 2.6B | 2.5B | 2.3B | 2.3B | 2.1B | 1.8B | 2.1B | 1.9B | 1.6B | |
GROSS PROFIT | ||||||||||||||||||||
(2.7B) | (2.2B) | (2.2B) | (2.2B) | (2.1B) | (1.8B) | (1.8B) | (1.8B) | (1.6B) | (1.5B) | (1.5B) | (1.8B) | (1.7B) | (1.6B) | (1.6B) | (1.4B) | (1.2B) | (1.4B) | (1.3B) | (1.1B) | |
1.1B | 1.4B | 1.3B | 1.2B | 1.2B | 1.1B | 1B | 951.8M | 865.1M | 832.9M | 814.5M | 842.5M | 811.1M | 740.7M | 768.9M | 697.9M | 615.9M | 660.4M | 608.4M | 515.1M | |
OPERATING INCOME | ||||||||||||||||||||
(605M) | (859M) | (859.4M) | (784.6M) | (809.3M) | (747M) | (649.2M) | (601.7M) | (541.4M) | (522.4M) | (490.4M) | (536.1M) | (514.7M) | (478.7M) | (481.9M) | (429.8M) | (417.6M) | (432M) | (397.7M) | (353.5M) | |
(499.9M) | (582.2M) | (565.8M) | (544.3M) | (551.2M) | (500.2M) | (454.6M) | (430M) | (388.3M) | (367.6M) | (351.5M) | (383.9M) | (364.7M) | (341.6M) | (347.6M) | (296.9M) | (277M) | (300.8M) | (274.2M) | (238.9M) | |
(105.1M) | (0.0) | (0.0) | (0.0) | (99.8M) | (92.5M) | (82.8M) | (75.3M) | (68.2M) | (66.2M) | (67.1M) | (76.2M) | (71.8M) | (65.4M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
512.3M | 496.5M | 404M | 379.3M | 347.3M | 339.5M | 371.7M | 286.3M | 321.5M | 310.5M | 324.1M | 306.4M | 284.6M | 258.9M | 287M | 268.1M | 205.9M | 228.4M | 210.7M | 161.6M | |
PRE-TAX INCOME | ||||||||||||||||||||
(52.7M) | (43.9M) | (40.4M) | (40.8M) | (30.3M) | (33.2M) | (35.5M) | (32.6M) | (40.6M) | (35.2M) | (34.6M) | (21M) | (20.5M) | (19M) | (17.3M) | (14.4M) | (16.5M) | (18.7M) | (19.5M) | (0.0) | |
-41.1M | -31.8M | -36M | -38.1M | -26.6M | -32.3M | -31.3M | -25.6M | -35.1M | -32.6M | -29M | -16.2M | -17.3M | -16M | -11.6M | -11.1M | -13.2M | -5.6M | -10.6M | 0.0 | |
(0.0) | (276.8M) | (293.6M) | (240.3M) | (158.3M) | (154.3M) | (111.8M) | (5.6M) | (8.7M) | (2.8M) | (163K) | -2M | -2M | -1.1M | (134.2M) | (133M) | (133M) | (131.1M) | (123.5M) | (114.6M) | |
-21M | -26.7M | -29.2M | -44.6M | -25.7M | -38.3M | -29.6M | -20.2M | -28.7M | -35.6M | -29.6M | -20.1M | -34.7M | -17.5M | -12.1M | -13.7M | -21.9M | -7.4M | -10.7M | -13.3M | |
491.4M | 469.8M | 374.8M | 334.7M | 321.7M | 301.2M | 342.1M | 266M | 294.8M | 280.5M | 294.6M | 286.3M | 264.4M | 241.4M | 274.9M | 254.4M | 184.1M | 221M | 200M | 148.3M | |
NET INCOME | ||||||||||||||||||||
(98.9M) | (95.6M) | (90.6M) | (95.1M) | (78M) | (87.1M) | (99.8M) | (71.3M) | (74.8M) | (74.9M) | (95.3M) | (94.7M) | (92.5M) | (79M) | (91.3M) | (80.8M) | (59.5M) | (67.5M) | (60.5M) | (45.4M) | |
392.8M | 374.5M | 284.5M | 239.3M | 244.1M | 214M | 242.2M | 194.7M | 220M | 205.6M | 199.3M | 191.7M | 172M | 162.6M | 183.7M | 173.5M | 124.6M | 153.5M | 141.7M | 102.9M |
ATR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 13, 2026 | May 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 06, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 01, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 27, 2026 | May 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 17, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 06, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 20, 2025 | November 20, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | October 31, 2025 | September 30, 2025 | 2025 |
Continue your ATR research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.